User profiles for Mohit Kumar Jolly

Mohit Kumar Jolly

Associate Professor, Indian Institute of Science, Bangalore
Verified email at iisc.ac.in
Cited by 10922

[HTML][HTML] Implications of the hybrid epithelial/mesenchymal phenotype in metastasis

MK Jolly, M Boareto, B Huang, D Jia, M Lu… - Frontiers in …, 2015 - frontiersin.org
Transitions between epithelial and mesenchymal phenotypes – the epithelial to mesenchymal
transition (EMT) and its reverse the mesenchymal to epithelial transition (MET) – are …

The physics of cellular decision making during epithelial–mesenchymal transition

S Tripathi, H Levine, MK Jolly - Annual Review of Biophysics, 2020 - annualreviews.org
The epithelial–mesenchymal transition (EMT) is a process by which cells lose epithelial traits,
such as cell–cell adhesion and apico-basal polarity, and acquire migratory and invasive …

A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells

…, K Hari, S Muralidharan, S Mandal, MK Jolly - NAR …, 2021 - academic.oup.com
Resistance to anti-estrogen therapy is an unsolved clinical challenge in successfully treating
ER+ breast cancer patients. Recent studies have demonstrated the role of non-genetic (ie …

MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination

M Lu, MK Jolly, H Levine… - Proceedings of the …, 2013 - National Acad Sciences
Forward and backward transitions between epithelial and mesenchymal phenotypes play
crucial roles in embryonic development and tissue repair. Aberrantly regulated transitions are …

Tumor budding: the name is EMT. Partial EMT.

AD Grigore, MK Jolly, D Jia, MC Farach-Carson… - Journal of clinical …, 2016 - mdpi.com
Tumor budding is a histological phenomenon encountered in various cancers, whereby
individual malignant cells and/or small clusters of malignant cells are seen in the tumor stroma. …

[HTML][HTML] Stability of the hybrid epithelial/mesenchymal phenotype

MK Jolly, SC Tripathi, D Jia, SM Mooney, M Celiktas… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Epithelial-to-Mesenchymal Transition (EMT) and its reverse–Mesenchymal to Epithelial
Transition (MET)–are hallmarks of cellular plasticity during embryonic development and cancer …

EMT and MET: necessary or permissive for metastasis?

MK Jolly, KE Ware, S Gilja, JA Somarelli… - Molecular …, 2017 - Wiley Online Library
Epithelial‐to‐mesenchymal transition ( EMT ) and its reverse mesenchymal‐to‐epithelial
transition ( MET ) have been suggested to play crucial roles in metastatic dissemination of …

Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing

…, R Soundararajan, MK Jolly… - Proceedings of the …, 2021 - National Acad Sciences
The epithelial-to-mesenchymal transition (EMT) plays a critical role during normal development
and in cancer progression. EMT is induced by various signaling pathways, including TGF…

Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer

…, NB Ognjenovic, KE Muller, MK Jolly… - Science …, 2022 - science.org
The epithelial-to-mesenchymal transition (EMT) is frequently co-opted by cancer cells to
enhance migratory and invasive cell traits. It is a key contributor to heterogeneity, …

Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas

MK Jolly, JA Somarelli, M Sheth, A Biddle… - Pharmacology & …, 2019 - Elsevier
Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and
account for nearly all cancer-related deaths. Both metastasis and therapy resistance are …